NCT02227446View on ClinicalTrials.gov

Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,036

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

November 30, 2019

Conditions
Post Operative Surgical Site Infection
Interventions
DRUG

Vancomycin antibiotic powder

At the time of fracture fixation 1000 mg of Vancomycin powder placed into the wound during wound closure.

Trial Locations (1)

21201

University of Maryland R Adams Cowley Shock Trauma Center, Baltimore

All Listed Sponsors
lead

Major Extremity Trauma Research Consortium

OTHER

NCT02227446 - Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO) | Biotech Hunter | Biotech Hunter